Estate and inheritance taxes are burdensome. They disincentivize investment and can drive high-net-worth individuals out of state. They also yield estate planning and tax avoidance strategies that are inefficient, not only for affected taxpayers but also for the economy at large. The handful of states that still impose them should consider gradually eliminating them or
admin
In this article GM Follow your favorite stocksCREATE FREE ACCOUNT 2026 Cadillac Vistiq EV GM DETROIT — General Motors‘ newest all-electric vehicle is a three-row SUV for its Cadillac luxury line, which the brand is dubbing a “baby Escalade.” The 2026 Cadillac Vistiq will be the last in a lineup of new EVs in the brand’s
In this article HD Follow your favorite stocksCREATE FREE ACCOUNT Home Depot’s quarterly sales rose more than 6% year over year, as it folded in a newly acquired business and hurricane-related repairs and better weather in many parts of the country boosted demand for home improvement supplies, the company said Tuesday. The retailer also raised
Alibaba International promotes its e-commerce platform for small businesses at the Canton Fair in Guangdong, China, on Oct. 16, 2024. Vcg | Visual China Group | Getty Images BEIJING — Chinese e-commerce giant Alibaba on Tuesday unveiled an artificial intelligence-powered search engine for small businesses in Europe and the Americas to source supplies. It’s an
The stock market could enjoy a bigger boost from President-elect Donald Trump than any previous administration thanks to his pro-business policies, according to Jeremy Siegel, finance professor at the Wharton School of the University of Pennsylvania. “President-elect Trump is the most pro-stock market president we have had in our history,” Siegel said on CNBC’s “Squawk Box”
Baona | E+ | Getty Images Many Americans haven’t saved enough for retirement. However, a big change to 401(k) plans could provide a boost for older workers. The IRS in November unveiled higher 401(k) contribution limits for 2025, with employee deferrals jumping to $23,500, up from $23,000 in 2024. While the catch-up contribution remains unchanged
Mixetto | E+ | Getty Images The share of Americans with credit-card debt in retirement has jumped considerably — a worrisome financial trend, especially for those with little wiggle room in their budgets, experts said. About 68% of retirees had outstanding credit-card debt in 2024, up “substantially” from 40% in 2022 and 43% in 2020,
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market rotation: The Dow was the big winner Monday, tracking for its first close above 44,000. However, the pressure on the S & P 500 and
A sign is displayed outside a Toyota Motor Corp. dealership on Jan. 30, 2024 in Tokyo, Japan. Tomohiro Ohsumi | Getty Images News | Getty Images DETROIT — Toyota Motor sounded the alarm Friday that California-led electric vehicle mandates that are set to start next year are “impossible” to meet and, if they’re not changed,
An Airbus A350-941 from Singapore Airlines is preparing to take off on the runway at Barcelona-El Prat Airport in Barcelona, Spain, on May 1, 2024. Nurphoto | Nurphoto | Getty Images SINGAPORE — Shares of Singapore Airlines dropped after the city-state’s flag carrier reported a fall of almost 50% in net profit for its first half
Neel Kashkari, President and CEO, Federal Reserve Bank of Minneapolis, speaks at the Milken Conference 2024 Global Conference Sessions at The Beverly Hilton in Beverly Hills, California, U.S., May 7, 2024. David Swanson | Reuters Minneapolis Federal Reserve President Neel Kashkari said Sunday that President-elect Donald Trump’s tariff proposals could worsen long-term inflation if global
In this article VRP-GB Follow your favorite stocksCREATE FREE ACCOUNT Rafael Henrique | SOPA Images | AP Company: Verona Pharma (VRNA) Business: Verona Pharma, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company’s product candidate is ensifentrine, an inhaled and